> At this point the only entities large enough to make a difference are probably the NIH and NSF in the U.S. and the relevant EU funding agencies in Europe. I

> At this point the only entities large enough to make a difference are probably the NIH and NSF in the U.S. and the relevant EU funding agencies in Europe. I m really not sure about that as the publishing bubble coincides with the rise in funding by public bodies [1]. Funding safe projects is a way to disperse funds to as many people as possible, and that's not necessarily good. At least in EU it feels that way. The politics of funding seem to naturally have gravitated to the current situation. I doubt the model of funding can change with the same stakeholders. [1] https://phoenixrising.me/wp-content/uploads/NIH_Total-Funding_87_2010.jpg https://phoenixrising.me/wp-content/uploads/NIH_Total-Fundin... , https://www.researchgate.net/publication/327917254/figure/fig1/AS:677815078887426@1538615116716/The-annual-rate-of-publications-in-the-biomedical-domain-as-indexed-by-PubMed-The.png https://www.researchgate.net/publication/327917254/figure/fi...